Published in Vaccine Weekly, April 12th, 1999
The U.S. Centers for Disease Control and Prevention's (CDC's) Artic Investigations Program examined the efficacy of the combined vaccine in a group of native Alaskan infants ("Immunogenicity of a Combined Hepatitis B and Hemophilus influenzae Type B Conjugate Vaccine in Alaska Native Infants," Int J Circumpolar Health, 1999; 57 Suppl 1:285-292).
Hepatitis B and Hemophilus influenzae b (Hib), prevalent diseases in Alaska Native infants, have been reduced 95 percent following universal vaccination. Therefore,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly